Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/24/2010CN101890009A Application of novel antitumor cell compound
11/24/2010CN101890008A Amoxicillin sodium/sulbactam sodium composition microsphere injection
11/24/2010CN101890007A Amoxicillin sodium potassium clavulanate composition microballoon injection
11/24/2010CN101890006A Amoxicillin sustained-release preparation composition and preparation method thereof
11/24/2010CN101890005A Amoxicillin/clavulanate potassium enteric-coated preparation composition and preparation method thereof
11/24/2010CN101890004A Amoxicillin/potassium clavulanate sustained-release preparation composition and preparation method thereof
11/24/2010CN101890003A Method for preparing novel chlorhexidine acetate cream
11/24/2010CN101890002A Application of phenylpropylthiophene derivative in preparation of anti-HIV medicament
11/24/2010CN101890001A Medicinal composition of bifendate
11/24/2010CN101890000A Application of gambogic acid as inhibitor of heat shock protein 90
11/24/2010CN101889999A Tyrosinase inhibitor for inhibiting melanogenesis of normal human melanocytes
11/24/2010CN101889998A Composition and application thereof as TR3 receptor inducer
11/24/2010CN101889997A Ibuprofen-containing medicinal composition for injection
11/24/2010CN101889996A Rectal administration composition containing tamsulosin
11/24/2010CN101889995A Drug application of 4-((3-(((2-naphthoxy)acetyl)hydrazo)butyryl)amine) benzamide
11/24/2010CN101889994A Salbutamol sulfate sustained-release aerosol of micropowder for inspiration and preparation method thereof
11/24/2010CN101889993A Surface-modified salbutamol suspension type non-Freon inhalation aerosol and preparation method thereof
11/24/2010CN101889992A Application of 2,4-dihydroxy benaophenonel in preparing medicament for treating hepatitis
11/24/2010CN101889991A Application of alpha-asarin
11/24/2010CN101889990A Ondansetron film compositions
11/24/2010CN101889989A Amoxicillin enteric controlled-release preparation composite and preparation method thereof
11/24/2010CN101889988A Tiamulin fumarate effervescent granules for treating pneumonia and dysentery of livestock and poultry
11/24/2010CN101889987A Method for preparing novel cefixime tablets and cefixime capsules
11/24/2010CN101889986A Flunarizine orally disintegrating tablet and preparation method thereof
11/24/2010CN101889985A Medicament-carrying nano microspheres and preparation method thereof
11/24/2010CN101889984A Amoxicillin enteric-coated formulation composition and preparation method thereof
11/24/2010CN101889982A Novel long-circulating liposome composition and preparation method thereof
11/24/2010CN101889981A Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents
11/24/2010CN101889979A Itraconazole injection for dogs and preparation method thereof
11/24/2010CN101889978A Pharmaceutical composition containing vinpocetine, preparation method and application thereof
11/24/2010CN101889977A Pyritinol hydrochloride injection and preparation method thereof
11/24/2010CN101889976A Acyclovir injection and preparation method thereof
11/24/2010CN101889975A Rosuvastatin calcium sustained-release preparation and preparation method thereof
11/24/2010CN101889973A Itraconazole gel for dogs and preparation method thereof
11/24/2010CN101889972A Preparation of TCH/HNTs/PLGA nanometer composite fibre medicine carrying system
11/24/2010CN101889679A Composition with disintoxicating and liver-protecting effects and application thereof in food and health-care food
11/24/2010CN101380302B Potasium dehydroandrographolide succinate injection and production method thereof
11/24/2010CN101327187B Nonoxynol nonylphenoxy-polyethoxyethanol suppositorium and preparation method thereof
11/24/2010CN101318965B Hairy sepal ponicidin crystallization, preparation method and medicament composition containing the same
11/24/2010CN101317836B Application of (3aR,5R,11bR)-3,3a,5,11b-tetrahydro-7-hydroxyl-5-methyl-2H-furo[3,2-b]naphtho[2,3-d]pyran -2,6,11-trione
11/24/2010CN101314579B Waterless Peramivir crystal and medicament composition thereof
11/24/2010CN101297800B Compound taurine soluble powder for curing hepatitis of dogs and preparation thereof
11/24/2010CN101274100B Method for preparing adriamycin-dipeptide complexes and applications
11/24/2010CN101262847B Stable pharmaceutical composition comprising a pyrimidine-sulfamide
11/24/2010CN101235097B Method for extracting polysaccharide from angelica and application thereof
11/24/2010CN101235019B 3,5-diiodo salicylaldehyde-4-(omega-aminoalkyl)morpholine metal complexes, preparation method and use thereof
11/24/2010CN101234116B Powder needle injection containing caderofloxacin lactate
11/24/2010CN101234115B Water needle injection containing caderofloxacin lactate
11/24/2010CN101233105B Tryptophan derivative and use thereof
11/24/2010CN101230043B 3-oxide-2-methylamide derivatives as well as preparation method and use thereof
11/24/2010CN101229244B Adjuvant therapy rheumatoid arthritis external medicine and preparing method thereof
11/24/2010CN101229183B Ribonucleic acid retrogradation snippet compound and applications thereof
11/24/2010CN101229140B Nifedipine sustained release preparation and preparing method thereof
11/24/2010CN101229132B Nimodipine pulse sustained release mircopill preparation and preparing method thereof
11/24/2010CN101210020B Cephalosporin compound
11/24/2010CN101199504B Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament
11/24/2010CN101199476B Pennogenyl Saponins percutaneous-absorping preparation
11/24/2010CN101195627B New application of benzo [C] phenanthridine and protopine in producing overriding resistant bacterium medicament
11/24/2010CN101181472B Chinese medicine liqueur for curing trauma and burn
11/24/2010CN101181327B Chinese medicine compound preparations for preventing and curing cataptosis and chest bi-syndrome as well as preparation method thereof
11/24/2010CN101175722B Azetidine derivatives as ccr-3 receptor antagonists
11/24/2010CN101167730B Compound betamethasone suspension injection
11/24/2010CN101167720B Application of iridoids compound in preparing medicine for treating benign prostate hyperplasia
11/24/2010CN101160311B Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid
11/24/2010CN101155787B (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
11/24/2010CN101152202B Pharmaceutical composition for treating apparatus respiratorius disease and method for preparing the same
11/24/2010CN101152189B Polyene phosphatidyl choline injection and method for preparing the same
11/24/2010CN101139347B Banisterine derivative compound and uses thereof
11/24/2010CN101137361B Potassium channel opener having benzofuroindole skeleton
11/24/2010CN101129365B Analgesics use of ricinine
11/24/2010CN101121706B Coumarin derivatives, preparation method and use thereof
11/24/2010CN101121672B Betaine phosphate and its producing method and applicaiton
11/24/2010CN101120947B Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
11/24/2010CN101120945B Application of 8-arylamine-3H-imidazole [4, 5-g] quinazoline derivatives
11/24/2010CN101107243B Substituted triazole derivatives as oxytocin antagonists
11/24/2010CN101095691B Application of phillyrin in the preparing of medicine for treating or preventing acute and chronic liver injury and hepar fibrosis
11/24/2010CN101074233B 4'-demethylpodoph-yllotoxin derivative, its production and use
11/24/2010CN101062022B Colchicine patch absorbing from skin for treating acute goute arthritis and the preparing method thereof
11/24/2010CN101049297B High DNA type fatty ethyl ester in high purity, manufacturing method and preparation
11/24/2010CN101045715B Heterocycle inhibitor for glycogen synthase kinase gsk-3
11/24/2010CN101027032B Composition for prevention or alleviation of pigmentation
11/24/2010CN100998595B Medicine composition containing cefateram cyclodextrin capsule and its preparing method
11/23/2010US7838706 antimitotic; antitumor; ethylate 4-hydroxy-3-methoxybenzaldehyde with ethyl bromide to form the 4-ethoxy-; Wittig reaction with 3,4,5-trimethoxybenzyltriphenylphosphonium ylid; phosphorylation
11/23/2010US7838699 Embolization using degradable crosslinked hydrogels
11/23/2010US7838695 insecticides; act on calcium ion channels; antagonist of the toxic effects of insecticides in humans; 6S-acetyl-4R,5R-dimethyl-1R(10S)-epoxy-2R-hy-droxy-7R-acetoxydecahydro naphthalene; isolated from the coral Cnidarian Rhytisma fulvum
11/23/2010US7838682 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
11/23/2010US7838678 Process for preparing atazanavir bisulfate and novel forms
11/23/2010US7838675 Asthma, allergic rhinitis, COPD, inflammatory bowel disease, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis, or cancer; N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-[2-hydroxy-1-(hydroxymethyl)ethoxy]-4-pyrimidinyl]-1-azetidinesulfonamide for example
11/23/2010US7838673 [(1R)-2-(2-fluorophenyl)-1-({2-methyl-2-[(quinoxalin-2-ylcarbonyl)amino]propanoyl}amino)ethyl]boronic acid; useful for the treatment of various cell proliferative diseases
11/23/2010US7838672 7-Methoxy-1-methyl[1,2,4]triazolo[3,4-c][1,2,4]benzotriazine; pre-emergence and post-emergence herbicides
11/23/2010US7838644 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field
11/23/2010US7838637 Single-chain multiple antigen-binding molecule, its preparation and use
11/23/2010US7838565 Suppresses reduction in peripheral nerve conduction rate and alleviates hypofunction of bladder so that it is useful as a preventive and/or therapeutic agent for, particularly, diabetic neuropathy
11/23/2010US7838564 treatment of cutaneous T-cell lymphoma by topically applying composition of a Nitrogen Mustard or a HX salt of the Nitrogen Mustard to the affected skin, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol
11/23/2010US7838563 Compounds, formulations, and methods for ameliorating telangiectasias
11/23/2010US7838562 treating a mammal for a vascular permeability disorder by administering a vascular endothelial sphingosine-1-phosphate receptor agonist comprising 2-amino-2-[2-(4-octaphenyl)ethyl]propane-1,3 diol, or 2-amino-2-methyl-4-[4-heptoxy-phenyl]butane-1-ol
11/23/2010US7838561 administering to mammal or higher vertebrate an effective amount of a pharmaceutical composition comprising N-[4-hydroxyphenyl]retinamide
11/23/2010US7838560 Urokinase inhibitors, production and use thereof
11/23/2010US7838559 Neuronal sodium channel antagonist in combination with carbamate compounds; insect control and crop protection; nontoxic, environmentally friendly; low cost; reduced dosage rates
11/23/2010US7838558 adapalene in topical gels, creams or lotions in higher concentration for skin disorders such as acne
1 ... 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 ... 7860